Improvement in early function of the hepatic graft after treatment of the donor with N-acetylcysteine: clinical study

Transplant Proc. 1997 Dec;29(8):3350-2. doi: 10.1016/s0041-1345(97)00938-x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Adenosine
  • Alanine Transaminase / blood
  • Alkaline Phosphatase / blood
  • Allopurinol
  • Aspartate Aminotransferases / blood
  • Bile / metabolism
  • Bilirubin / blood
  • Glutathione
  • Graft Rejection / epidemiology
  • Humans
  • Insulin
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology*
  • Middle Aged
  • Organ Preservation / methods*
  • Organ Preservation Solutions*
  • Prothrombin Time
  • Raffinose
  • Survival Rate
  • Tissue Donors*

Substances

  • Insulin
  • Organ Preservation Solutions
  • University of Wisconsin-lactobionate solution
  • Allopurinol
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Alkaline Phosphatase
  • Glutathione
  • Adenosine
  • Raffinose
  • Bilirubin
  • Acetylcysteine